Xanodyne (Rights to Amicar) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 1

Xanodyne (Rights to Amicar) General Information

Description

Drug formulation for treatment of bleeding disorder. The drug is used for treatment for bleeding disorder in case of surgical complication.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Buildings and Property
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Acquirer
Primary Office
  • One Riverfront Place
  • Newport, KY 41071
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Xanodyne (Rights to Amicar) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Xanodyne (Rights to Amicar)‘s full profile, request access.

Request a free trial

Xanodyne (Rights to Amicar) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Xanodyne (Rights to Amicar)‘s full profile, request access.

Request a free trial